LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Naturally Fluorescent Coenzyme Level in Mitochondria Indicative of Disease

By LabMedica International staff writers
Posted on 14 Apr 2009
Print article
Image: Polarized light micrograph of crystals of the coenzyme nicotinamide adenine dinucleotide (NAD) (Photo courtesy of Alfred Pasieka / SPL).
Image: Polarized light micrograph of crystals of the coenzyme nicotinamide adenine dinucleotide (NAD) (Photo courtesy of Alfred Pasieka / SPL).
To distinguish between normal and cancerous cells, scientists measured the fluorescence of natural nicotinamide adenine dinucleotide (NADH).

NADH is a coenzyme, a non-protein molecule necessary for the functioning of an enzyme found mostly in the inner membrane of mitochondria. In the event of disease or a metabolic disorder, enzymes and their related reactions can become disabled, causing a buildup of unused NADH.

Using a combination of spectroscopy and microscopy techniques, fluorescence was converted into an accurate measure of NADH concentration in live cells. Ahmed Heikal, associate professor of bioengineering, Pennsylvania State University (Pittsburgh, PA, USA) and colleagues found that the average concentration of NADH in breast cancer cells is about twice that in normal breast cells.

"Dysfunctional enzymes in the mitochondria are known to be associated with serious health problems such as cancer and neurodegenerative diseases," said Professor Heikal. "By detecting the level of NADH and its distribution inside living cells, we should be able to monitor the mitochondrial activity and thus the integrity of any given cell, without adding potentially toxic dyes or actually destroying the cell."

One of the main challenges in cancer diagnosis is the ability to differentiate cancer cells from normal ones at the early stages of tumor progression. "If we are given two live cells, one normal and the other cancerous, we could differentiate between the two with confidence," said Professor Heikal.

The team developed a technique called rotational diffusion imaging to establish a direct measure of the concentrations of free and enzyme-bound NADH throughout a living cell, whether in the cytosol (cell fluid) or the mitochondria.

Other neurodegenerative diseases related to mitochondrial anomalies can also be detected with the new technique, which is not limited to detecting cancer. The ability to accurately measure NADH levels in a cell without killing it could have potential implications for related research on human health and drug delivery.

Related Links:
Pennsylvania State University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.